促卵泡生成素和促黄体生成素受体在卵巢癌生存中的相反作用。 - Suppr

Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.

作者信息

Lenhard Miriam, Lennerová Tereza, Ditsch Nina, Kahlert Steffen, Friese Klaus, Mayr Doris, Jeschke Udo

出版信息

Histopathology. 2011 May;58(6):990-4. doi: 10.1111/j.1365-2559.2011.03848.x.

DOI:10.1111/j.1365-2559.2011.03848.x

PMID:21585434

Abstract

摘要

相似文献

Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.

Histopathology. 2011 May;58(6):990-4. doi: 10.1111/j.1365-2559.2011.03848.x.

[Survival of patients with ovarian cancer in the Ul'ianovsk Region, 1999-2005].

Vopr Onkol. 2007;53(4):393-5.

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.

Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390.

Prognostic analysis of ovarian cancer associated with endometriosis.

Am J Obstet Gynecol. 2011 Jan;204(1):63.e1-7. doi: 10.1016/j.ajog.2010.08.017. Epub 2010 Nov 11.

Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.

Clin Cancer Res. 2006 Mar 1;12(5):1487-93. doi: 10.1158/1078-0432.CCR-05-2106.

[Clinicopathologic features of 234 cases with borderline ovarian tumors].

Zhonghua Fu Chan Ke Za Zhi. 2009 Feb;44(2):116-20.

c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.

Endocr Relat Cancer. 2009 Jun;16(2):443-53. doi: 10.1677/ERC-08-0218. Epub 2009 Mar 25.

B7-H4 overexpression in ovarian tumors.

Gynecol Oncol. 2006 Jan;100(1):44-52. doi: 10.1016/j.ygyno.2005.08.060. Epub 2005 Oct 26.

Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.

Gynecol Oncol. 2017 Feb;144(2):414-419. doi: 10.1016/j.ygyno.2016.11.038. Epub 2016 Nov 28.

Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.

Arch Gynecol Obstet. 2004 Nov;270(3):151-6. doi: 10.1007/s00404-003-0519-4. Epub 2003 Jul 23.

引用本文的文献

Follicle-Stimulating Hormone Receptor Expression and Its Potential Application for Theranostics in Subtypes of Ovarian Tumors: A Systematic Review.

Cancers (Basel). 2024 Mar 13;16(6):1140. doi: 10.3390/cancers16061140.

A follicle-stimulating hormone receptor-targeted near-infrared fluorescent probe for tumor-selective imaging and photothermal therapy.

Mater Today Bio. 2023 Dec 7;24:100904. doi: 10.1016/j.mtbio.2023.100904. eCollection 2024 Feb.

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer.

Int J Mol Sci. 2022 Feb 28;23(5):2698. doi: 10.3390/ijms23052698.

Overview of follicle stimulating hormone and its receptors in reproduction and in stem cells and cancer stem cells.

Int J Biol Sci. 2022 Jan 1;18(2):675-692. doi: 10.7150/ijbs.63721. eCollection 2022.

Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).

Oncol Rep. 2021 Oct;46(4). doi: 10.3892/or.2021.8174. Epub 2021 Aug 26.

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype.

Int J Mol Sci. 2020 Dec 23;22(1):71. doi: 10.3390/ijms22010071.

Glycoprotein G-protein Coupled Receptors in Disease: Luteinizing Hormone Receptors and Follicle Stimulating Hormone Receptors.

Diseases. 2020 Sep 15;8(3):35. doi: 10.3390/diseases8030035.

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.

J Cancer Res Clin Oncol. 2020 Aug;146(8):1923-1932. doi: 10.1007/s00432-020-03241-7. Epub 2020 Jun 12.

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.

BMC Cancer. 2019 Nov 15;19(1):1114. doi: 10.1186/s12885-019-6153-8.

Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings.

Antibodies (Basel). 2017 Oct 18;6(4):15. doi: 10.3390/antib6040015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献